Cargando…

Raising cut-off value of prostate specific antigen (PSA) for biopsy in symptomatic men in India to reduce unnecessary biopsy

BACKGROUND & OBJECTIVES: The characteristics of prostate specific antigen (PSA) for trans-rectal ultrasonography guided prostate biopsy in men with lower urinary tract symptoms (LUTS) are not well defined. This study was carried out to analyse the threshold of PSA for biopsy in symptomatic men i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Agnihotri, Shalini, Mittal, R.D., Kapoor, R., Mandhani, Anil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164997/ https://www.ncbi.nlm.nih.gov/pubmed/25109719

Ejemplares similares

Free to total serum prostate specific antigen ratio in symptomatic men does not help in differentiating benign from malignant disease of the prostate
por: Agnihotri, Shalini, et al.
Publicado: (2014)

Validating fPSA Glycoprofile as a Prostate Cancer Biomarker to Avoid Unnecessary Biopsies and Re-Biopsies
por: Bertok, Tomas, et al.
Publicado: (2020)

Pre-biopsy MRI as an adjunct for cancer detection in men with elevated PSA and no previous biopsy
por: Uriburu-Pizarro, Facundo, et al.
Publicado: (2017)

Using clinical parameters to predict prostate cancer and reduce the unnecessary biopsy among patients with PSA in the gray zone
por: Liu, Junxiao, et al.
Publicado: (2020)

Avoiding unnecessary sentinel node biopsy
por: Jeffree, JS, et al.
Publicado: (2006)

The Role of PSA Density among PI-RADS v2.1 Categories to Avoid an Unnecessary Transition Zone Biopsy in Patients with PSA 4-20 ng/mL
por: Wang, Zhi-bing, et al.
Publicado: (2021)

Relationship between initial PSA density with future PSA kinetics and repeat biopsies in men with prostate cancer on active surveillance
por: Kotb, A F, et al.
Publicado: (2011)

Optimal PSA Threshold for Obtaining MRI-Fusion Biopsy in Biopsy-Naïve Patients
por: Wang, Luke L., et al.
Publicado: (2021)

Preventing Unnecessary Invasive Cancer-Diagnostic Tests: Changing the Cut-off Points
por: Pourmand, G, et al.
Publicado: (2012)

Assessment of Raman Spectroscopy for Reducing Unnecessary Biopsies for Melanoma Screening
por: Zhang, Yao, et al.
Publicado: (2020)

Impact of PSA density of transition zone as a potential parameter in reducing the number of unnecessary prostate biopsies in patients with PSA levels between 2.6 and 10.0 ng/mL
por: Castro, Hugo A. Socrates, et al.
Publicado: (2018)

Ultrasound‐based radiomics score for pre‐biopsy prediction of prostate cancer to reduce unnecessary biopsies
por: Ou, Wei, et al.
Publicado: (2022)

Serum testosterone as a biomarker for second prostatic biopsy in men with negative first biopsy for prostatic cancer and PSA>4ng/mL, or with PIN biopsy result
por: Fiamegos, Alexandros, et al.
Publicado: (2016)

Poor reproducibility of PIRADS score in two multiparametric MRIs before biopsy in men with elevated PSA
por: Müller, Stig, et al.
Publicado: (2018)

New transperineal ultrasound-guided biopsy for men in whom PSA is increasing after Miles’ operation
por: Park, Byung Kwan, et al.
Publicado: (2023)

Prostate biopsy for elevated prostate specific antigen (PSA) – Indian perspective
por: Ragavan, N.
Publicado: (2014)

Renal cell carcinoma in India demonstrates early age of onset & a late stage of presentation
por: Agnihotri, Shalini, et al.
Publicado: (2014)

Molecular cystoscopy: Micro-RNAs could be a marker for identifying genotypic changes for transitional cell carcinoma of the urinary bladder
por: Mitash, Nilay, et al.
Publicado: (2016)

Outcome of Prostate Biopsy in Men Younger than 40 Years of Age with High Prostate-Specific Antigen (PSA) Levels
por: Yang, Jin Bak, et al.
Publicado: (2010)

An optimized prostate biopsy strategy in patients with a unilateral lesion on prostate magnetic resonance imaging avoids unnecessary biopsies
por: Jager, Auke, et al.
Publicado: (2022)

A Comparative Performance Analysis of Total PSA, Percentage Free PSA, PSA Velocity, and PSA Density versus the Detection of Primary Circulating Prostate Cells in Predicting Initial Prostate Biopsy Findings in Chilean Men
por: Murray, Nigel P., et al.
Publicado: (2014)

Early Experience with MRI-ultrasound Fusion-guided Prostate Biopsy in Japanese Men with Elevated PSA Levels
por: Tamada, Tsutomu, et al.
Publicado: (2019)

The Relationship between Prostate Biopsy Results and PSA and Free PSA Ratio Changes in Elevated Serum PSA Patients with and without Antibiotherapy
por: Duran, Mesut Berkan, et al.
Publicado: (2020)

Does En-bloc transurethral resection of bladder tumor give a better yield in terms of presence of detrusor muscle in the biopsy specimen?
por: Upadhyay, Rohit, et al.
Publicado: (2012)

Developing a Follow-Up Strategy for Patients with PSA Ranging from 4 to 10 ng/ml via a New Model to Reduce Unnecessary Prostate Biopsies
por: Zhao, Ruizhe, et al.
Publicado: (2014)

Multivariable Models Incorporating Multiparametric Magnetic Resonance Imaging Efficiently Predict Results of Prostate Biopsy and Reduce Unnecessary Biopsy
por: Yu, Shuanbao, et al.
Publicado: (2020)

Does PSA reduction after antibiotic therapy permits postpone prostate biopsy in asymptomatic men with PSA levels between 4 and 10ng/mL?
por: Busato, W. F. S., et al.
Publicado: (2015)

Does normalizing PSA after successful treatment of chronic prostatitis with high PSA value exclude prostatic biopsy?
por: Azab, Sherif, et al.
Publicado: (2012)

Does prostate-specific antigen (PSA) mass or free PSA mass improve the accuracy of predicting total prostate volume in relation to obesity in men with biopsy-proven benign prostatic hyperplasia?
por: Jung, Jin-Woo, et al.
Publicado: (2019)

Is en-bloc transurethral resection of bladder tumor for non-muscle invasive bladder carcinoma better than conventional technique in terms of recurrence and progression?: A prospective study
por: Sureka, Sanjoy Kumar, et al.
Publicado: (2014)

Prostate-specific antigen kinetics contributes to decision making for biopsy referral: the predictive implication for PSA retest in patients with elevated PSA levels
por: Kobayashi, Minoru, et al.
Publicado: (2023)

Bladder cancer: Micro RNAs as biomolecules for prognostication and surveillance
por: Mitash, Nilay, et al.
Publicado: (2017)

Raised BMI cut-off for overweight in Greenland Inuit – a review
por: Andersen, Stig, et al.
Publicado: (2013)

Brush off the brush biopsy
por: Daftary, Dinesh K
Publicado: (2015)

Prostate-specific antigen screening of men with lower urinary tract symptoms (opportunistic screening) and of asymptomatic men undergoing executive health check: an audit from two institutions
por: Mandhani, Anil, et al.
Publicado: (2021)

Reducing Unnecessary Biopsies Using Digital Breast Tomosynthesis and Ultrasound in Dense and Nondense Breasts
por: Hadadi, Ibrahim, et al.
Publicado: (2022)

Targeted 11C–choline PET-CT/TRUS software fusion-guided prostate biopsy in men with persistently elevated PSA and negative mpMRI after previous negative biopsy
por: Lazzeri, Massimo, et al.
Publicado: (2017)

Epigenetic analyses in blood cells of men suspected of prostate cancer predict the outcome of biopsy better than serum PSA levels
por: Cytron, Samuel, et al.
Publicado: (2011)

The accuracy of multiparametric MRI in men with negative biopsy and elevated PSA level—Can it rule out clinically significant prostate cancer?
por: Abd-Alazeez, Mohamed, et al.
Publicado: (2014)

Comparison of PSA density and lesion volume strategies for selecting men with equivocal PI-RADS 3 lesions on bpMRI for biopsies
por: Kortenbach, Karen-Cecilie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_egi175tcjlab939um0rbe1qhv4